Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter H Jones

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Texas Heart Institute Journal|June 16, 2010
Update on lipids and C-reactive protein in acute and chronic coronary heart diseasePeter H Jones
Texas Heart Institute Journal|August 2, 2006
Lipids: new guidelines, intensive treatment, and future directionsPeter H Jones
The American Journal of Cardiology|December 17, 2008
Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol loweringPeter H Jones
Postgraduate Medicine|August 12, 2009
The power of statins: aggressive lipid loweringPeter H Jones
Cleveland Clinic Journal of Medicine|October 1, 2005
Statins: the case for higher, individualized starting dosesPeter H Jones
The American Journal of Managed Care|September 19, 2003
Atherosclerosis target of lipid-lowering therapy: is lower LDL cholesterol better?Peter H Jones
Postgraduate Medicine|August 12, 2009
Achieving cholesterol goals. Current and future drug therapiesPeter H Jones
Preventive Cardiology|April 11, 2006
Rationale for intensive statin treatment in high-risk patientsPeter H Jones
Clinical Cardiology|January 24, 2003
Comparing HMG-CoA reductase inhibitorsPeter H Jones
The American Journal of Geriatric Cardiology|July 20, 2006
Dyslipidemia in older adultsPeter H Jones
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Texas Heart Institute Journal|June 16, 2010
Update on lipids and C-reactive protein in acute and chronic coronary heart diseasePeter H Jones
Texas Heart Institute Journal|August 2, 2006
Lipids: new guidelines, intensive treatment, and future directionsPeter H Jones
The American Journal of Cardiology|December 17, 2008
Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol loweringPeter H Jones
Postgraduate Medicine|August 12, 2009
The power of statins: aggressive lipid loweringPeter H Jones
Cleveland Clinic Journal of Medicine|October 1, 2005
Statins: the case for higher, individualized starting dosesPeter H Jones
The American Journal of Managed Care|September 19, 2003
Atherosclerosis target of lipid-lowering therapy: is lower LDL cholesterol better?Peter H Jones
Postgraduate Medicine|August 12, 2009
Achieving cholesterol goals. Current and future drug therapiesPeter H Jones
Preventive Cardiology|April 11, 2006
Rationale for intensive statin treatment in high-risk patientsPeter H Jones
Clinical Cardiology|January 24, 2003
Comparing HMG-CoA reductase inhibitorsPeter H Jones
The American Journal of Geriatric Cardiology|July 20, 2006
Dyslipidemia in older adultsPeter H Jones
Pageof 11